Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Wages, Salaries and Other
Ratios

Revolution Medicines (RVMD) Receivables - Other (2019 - 2020)

Revolution Medicines has reported Receivables - Other over the past 2 years, most recently at $6.4 million for Q4 2020.

  • Quarterly results put Receivables - Other at $6.4 million for Q4 2020, down 26.83% from a year ago — trailing twelve months through Dec 2020 was $6.4 million (down 26.83% YoY), and the annual figure for FY2020 was $6.4 million, down 26.83%.
  • Receivables - Other for Q4 2020 was $6.4 million at Revolution Medicines, down from $9.3 million in the prior quarter.
  • Over the last five years, Receivables - Other for RVMD hit a ceiling of $9.3 million in Q3 2020 and a floor of $6.4 million in Q4 2020.